Universal-Beteiligungs- und Servicegesellschaft
PCRX icon

Universal-Beteiligungs- und Servicegesellschaft’s Pacira BioSciences PCRX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
80,017
+10,920
+16% +$243K ﹤0.01% 1283
2025
Q4 		$1.79M Buy
69,097
+54,079
+360% +$1.29M ﹤0.01% 1290
2025
Q3 		$387K Sell
15,018
-2,624
-15% -$64.5K ﹤0.01% 1825
2025
Q2 		$422K Buy
17,642
+1,856
+12% +$46.8K ﹤0.01% 1727
2025
Q1 		$392K Buy
+15,786
New +$378K ﹤0.01% 1703

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return